๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

FOSCARNET IN FULMINANT HEPATITIS B

โœ Scribed by PRICE, J

Book ID
122956443
Publisher
The Lancet
Year
1986
Tongue
English
Weight
177 KB
Volume
328
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Foscarnet therapy in chronic hepatitis B
Foscarnet therapy in chronic hepatitis B virus e antigen carriers
โœ V. G. Bain; H. M. Daniels; A. Chanas; G. J. M. Alexander; Dr. Roger Williams ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 343 KB ๐Ÿ‘ 2 views

Foscarnet (trisodium phosphonoformate) is a novel antiviral agent that inhibits viral-specific DNA polymerase. In the present study, eight males with chronic HBV carriage (HBeAg and HBV-DNA seropositivity >I2 months) showing chronic persistent hepatitis (CPH) or chronic active hepatitis (CAH) on liv

Fulminant Hepatitis in Asymptomatic Hepa
Fulminant Hepatitis in Asymptomatic Hepatitis B Surface Antigen Carriers in Greece
โœ Nicolaos C. Tassopoulos; George J. Papaevangelou; Anastasia Roumeliotou-Karayann ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 565 KB

Eleven male fulminant hepatitis (FH) patients (mean age: 47.7 +/- 16 years) positive for hepatitis B surface antigen (HBsAg) but negative for IgM antibody to hepatitis B core antigen (IgM anti-HBc) were admitted consecutively to the Athens Hospital for Infectious Diseases between May 1981 and Novemb